Monday, September 14, 2026

Metabia Begins Dosing First Patient in Phase 1 Part 3 Trial of Obesity Drug DA-1726

Metabia begins Phase 1 trial for DA-1726, a dual-action obesity treatment, aiming for safety and efficacy in weight loss by 2026.

DDM Immune Prep Delivers 100% Survival Against Drug-Resistant Bacteria and Flu in Pre-Exposure Tests

Researchers develop a novel infection-prevention strategy using DDM, enhancing immune response against antibiotic-resistant pathogens.

Researchers Identify Bone Age Differences Between Limbs in Rare Pediatric Overgrowth Disorders

A study reveals children with congenital hemihypertrophy show differing bone maturation rates, impacting surgical planning for limb discrepancies.

Tag: young generation

No posts to display

Top News

- Our Sponsors Ad -

Follow us